These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11843927)

  • 21. Clinical characterization of a novel COCH mutation G87V in a Chinese DFNA9 family.
    Chen DY; Chai YC; Yang T; Wu H
    Int J Pediatr Otorhinolaryngol; 2013 Oct; 77(10):1711-5. PubMed ID: 23993205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genotype-phenotype Correlation Study in a Large Series of Patients Carrying the p.Pro51Ser (p.P51S) Variant in COCH (DFNA9): Part I-A Cross-sectional Study of Hearing Function in 111 Carriers.
    JanssensdeVarebeke SPF; Moyaert J; Fransen E; Bulen B; Neesen C; Devroye K; van de Berg R; Pennings RJE; Topsakal V; Vanderveken O; Van Camp G; Van Rompaey V
    Ear Hear; 2021 Nov-Dec 01; 42(6):1508-1524. PubMed ID: 34369416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DFNA9 is a progressive audiovestibular dysfunction with a microfibrillar deposit in the inner ear.
    Khetarpal U
    Laryngoscope; 2000 Aug; 110(8):1379-84. PubMed ID: 10942145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a novel COCH mutation, I109N, highlights the similar clinical features observed in DFNA9 families.
    Kamarinos M; McGill J; Lynch M; Dahl H
    Hum Mutat; 2001 Apr; 17(4):351. PubMed ID: 11295836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel DFNA9 mutation in the vWFA2 domain of COCH alters a conserved cysteine residue and intrachain disulfide bond formation resulting in progressive hearing loss and site-specific vestibular and central oculomotor dysfunction.
    Street VA; Kallman JC; Robertson NG; Kuo SF; Morton CC; Phillips JO
    Am J Med Genet A; 2005 Dec; 139A(2):86-95. PubMed ID: 16261627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hearing and vestibular deficits in the Coch(-/-) null mouse model: comparison to the Coch(G88E/G88E) mouse and to DFNA9 hearing and balance disorder.
    Jones SM; Robertson NG; Given S; Giersch AB; Liberman MC; Morton CC
    Hear Res; 2011 Feb; 272(1-2):42-8. PubMed ID: 21073934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absence of COCH mutations in patients with Meniere disease.
    Sanchez E; López-Escámez JA; López-Nevot MA; López-Nevot A; Cortes R; Martin J
    Eur J Hum Genet; 2004 Jan; 12(1):75-8. PubMed ID: 14704763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temporal bone histopathology in dominantly inherited audiovestibular syndrome.
    Ishiyama A; Ishiyama G; Lopez I; Jen J; Kim G; Baloh RW
    Neurology; 2004 Nov; 63(10):1859-62. PubMed ID: 15557502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenotype analysis of an Australian DFNA9 family with the 1109N COCH mutation.
    Pauw RJ; Huygen PL; Colditz GM; Cremers CW
    Ann Otol Rhinol Laryngol; 2011 Jun; 120(6):414-21. PubMed ID: 21774451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Genotype--phenotype correlation limits in sensorineural hearing loss: case report of a three-year-old child with a bilateral cochleovestibular impairment and a molecular variant of the COCH gene].
    Montava M; Roman S; Sigaudy S; Marlin S; Nicollas R; Triglia JM
    Rev Laryngol Otol Rhinol (Bord); 2012; 133(3):151-6. PubMed ID: 23590105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detailed hearing and vestibular profiles in the patients with COCH mutations.
    Tsukada K; Ichinose A; Miyagawa M; Mori K; Hattori M; Nishio SY; Naito Y; Kitajiri S; Usami S
    Ann Otol Rhinol Laryngol; 2015 May; 124 Suppl 1():100S-10S. PubMed ID: 25780252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cochlin immunostaining of inner ear pathologic deposits and proteomic analysis in DFNA9 deafness and vestibular dysfunction.
    Robertson NG; Cremers CW; Huygen PL; Ikezono T; Krastins B; Kremer H; Kuo SF; Liberman MC; Merchant SN; Miller CE; Nadol JB; Sarracino DA; Verhagen WI; Morton CC
    Hum Mol Genet; 2006 Apr; 15(7):1071-85. PubMed ID: 16481359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A targeted Coch missense mutation: a knock-in mouse model for DFNA9 late-onset hearing loss and vestibular dysfunction.
    Robertson NG; Jones SM; Sivakumaran TA; Giersch AB; Jurado SA; Call LM; Miller CE; Maison SF; Liberman MC; Morton CC
    Hum Mol Genet; 2008 Nov; 17(21):3426-34. PubMed ID: 18697796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DFNA9/COCH and its phenotype.
    Kemperman MH; Bom SJ; Lemaire FX; Verhagen WI; Huygen PL; Cremers CW
    Adv Otorhinolaryngol; 2002; 61():66-72. PubMed ID: 12408065
    [No Abstract]   [Full Text] [Related]  

  • 35. Vestibular impairment in a Dutch DFNA15 family with an L289F mutation in POU4F3.
    van Drunen FJ; Pauw RJ; Collin RW; Kremer H; Huygen PL; Cremers CW
    Audiol Neurootol; 2009; 14(5):303-7. PubMed ID: 19372648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel mutation in COCH-implications for genotype-phenotype correlations in DFNA9 hearing loss.
    Hildebrand MS; Gandolfo L; Shearer AE; Webster JA; Jensen M; Kimberling WJ; Stephan D; Huygen PL; Smith RJ; Bahlo M
    Laryngoscope; 2010 Dec; 120(12):2489-93. PubMed ID: 21046548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new autosomal dominant syndrome of idiopathic progressive vestibulo-cochlear dysfunction with middle-age onset.
    Verhagen WI; Huygen PL; Bles W
    Acta Otolaryngol; 1992 Nov; 112(6):899-906. PubMed ID: 1481659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Novel COCH Mutation Affects the vWFA2 Domain and Leads to a Relatively Mild DFNA9 Phenotype.
    Smits JJ; van Beelen E; Weegerink NJD; Oostrik J; Huygen PLM; Beynon AJ; Lanting CP; Kunst HPM; Schraders M; Kremer H; de Vrieze E; Pennings RJE
    Otol Neurotol; 2021 Apr; 42(4):e399-e407. PubMed ID: 33710989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical observation on acute low-frequency hearing loss without vertigo: the role of cochlear hydrops analysis masking procedure as initial prognostic parameter.
    Hong SK; Nam SW; Lee HJ; Koo JW; Kim DH; Kim DR; Kim H
    Ear Hear; 2013; 34(2):229-35. PubMed ID: 22976344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mild and variable audiometric and vestibular features in a third DFNA15 family with a novel mutation in POU4F3.
    de Heer AM; Huygen PL; Collin RW; Kremer H; Cremers CW
    Ann Otol Rhinol Laryngol; 2009 Apr; 118(4):313-20. PubMed ID: 19462854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.